
Sign up to save your podcasts
Or


Attorneys Brady Bizarro and Andrew Silverio discuss today’s senate committee hearing on GLP-1 drug pricing and strategies that self-funded employers are using to manage the extreme costs of these drugs while we wait and hope for congressional action.
By The Phia Group4.9
1717 ratings
Attorneys Brady Bizarro and Andrew Silverio discuss today’s senate committee hearing on GLP-1 drug pricing and strategies that self-funded employers are using to manage the extreme costs of these drugs while we wait and hope for congressional action.

78,542 Listeners

32,057 Listeners

228,094 Listeners

63,530 Listeners

2,248 Listeners

587 Listeners

240 Listeners

111,845 Listeners

29 Listeners

1,433 Listeners

10,109 Listeners

15,969 Listeners

36 Listeners

19,183 Listeners

16,200 Listeners